Showing results (11-20 of 580) with videos related to
Sort By:
Pageof 58
Blood|August 17, 2006
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogeneticsMichael Heuser, Gernot Beutel, Juergen Krauter, et al.Haematologica|August 16, 2019
Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemiaAmit Sharma, Nidhi Jyotsana, Razif Gabdoulline, et al.Annals of Hematology|April 27, 2011
Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplicationMareike Rickmann, Juergen Krauter, Kathrin Stamer, et al.Haematologica|September 2, 2011
Rare occurrence of DNMT3A mutations in myelodysplastic syndromesFelicitas Thol, Claudia Winschel, Andrea Lüdeking, et al.International Journal of Molecular Sciences|October 24, 2018
Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q DeletionSimone Feurstein, Kathrin Thomay, Winfried Hofmann, et al.Transplantation and Cellular Therapy|June 20, 2022
Increased Late Noncardiac Nonrelapse Mortality in Patients with Atrial Fibrillation Diagnosed During Their Hospital Stay for Allogeneic Stem Cell TransplantationCatherina Lueck, Victoria Panagiota, Elke Dammann, et al.Frontiers of Medicine in China|December 3, 2010
Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectivesFelicitas Thol, Arnold GanserCurrent Pharmaceutical Design|May 11, 2012
Immunosuppressive therapy for myelodysplastic syndromesChristiane Dobbelstein, Arnold GanserSeminars in Hematology|July 17, 2007
Risks and benefits of erythropoiesis-stimulating agents in cancer managementGernot Beutel, Arnold GanserExpert Review of Hematology|September 9, 2024
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinationsRabia Shahswar, Arnold GanserPageof 58